Hideo Fukuhara

Sapporo, 0600812, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Measles: Why the vaccine still works after 60 years.

Measles: Why the vaccine still works after 60 years.

Journal: Cell host & microbe

Published: May 04, 2026

Understanding the structure of measles virus and its implications for novel drug discovery.

Understanding the structure of measles virus and its implications for novel drug discovery.

Journal: Expert opinion on drug discovery

Published: August 18, 2025

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.

Journal: Journal of virology

Published: April 15, 2025

Evolutionary and structural basis of SLAMF1 utilization in morbilliviruses-Implications for host range and cross-species transmission.

Evolutionary and structural basis of SLAMF1 utilization in morbilliviruses-Implications for host range and cross-species transmission.

Journal: PLoS pathogens

Published: February 16, 2025

Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination.

Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination.

Journal: eLife

Published: July 24, 2024

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.

Journal: Communications biology

Published: April 03, 2024

Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.

Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.

Journal: Structure (London, England : 1993)

Published: September 07, 2023

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.

Journal: Nature communications

Published: December 12, 2022

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.

Journal: Cell host & microbe

Published: August 09, 2022

Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants.

Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants.

Journal: mAbs

Published: May 11, 2022

Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand specificity and how binding affects the G-protein interface.

Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand specificity and how binding affects the G-protein interface.

Journal: PLoS biology

Published: April 24, 2022

Low-Cost Cell-Surface-Mimic Analysis of Ligand Interactions of Biotinylated Immune Receptors Using Surface Plasmon Resonance.

Low-Cost Cell-Surface-Mimic Analysis of Ligand Interactions of Biotinylated Immune Receptors Using Surface Plasmon Resonance.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 06, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026